TABLE 2

Relationships between assessments of cardiovascular risk and BSI/selected individual components

	PWV m·s⁻¹		Troponin μg·L⁻¹		NT-proBNP pmol·L⁻¹		Fibrinogen g·L⁻¹		CRP mg·L⁻¹
	r/ρ	p-value	r/ρ	p-value	r/ρ	p-value	r/ρ	p-value	r/ρ	p-value
Subjects n	101		98		97		100		100
BSI	0.45	<0.001^#	0.52	<0.001^#	0.34	0.001^#	0.39	0.001^#	0.24	0.017^¶
Age	0.77	<0.001^#	0.59	<0.001^#	0.47	<0.001^#	0.28	0.012^¶	0.10	0.323
Annual exacerbation frequency
≥3 events·year^-1 (n=40)	10.5±2.7	0.011^¶	0.008 (0.004–0.013)	0.047^¶	11.0 (5.0–18.5)	0.293	3.5 (2.7–4.3)	0.253	4.8 (2.0–11.8)	0.005^¶
<3 events·year^-1 (n=61)	9.2±1.7	0.011^¶	0.005 (0.003–0.008)	0.047^¶	9.0 (3.0–17.0)	0.293	3.2 (2.7–3.9)	0.253	2.2 (0.5–5.4)	0.005^¶
FEV₁ L	−0.34	0.001^#	−0.42	<0.001^#	−0.34	0.001^#	−0.53	<0.001^#	−0.45	<0.001^#
FEV₁ % predicted	−0.02	0.832	−0.28	0.006^¶	−0.11	0.301	−0.43	<0.001^#	−0.34	0.001^#
CT lobes involved	0.14	0.159	0.17	0.091	0.24	0.02^¶	−0.07	0.570	0.07	0.482

Data are presented as mean±sd or median (interquartile range), unless otherwise stated. Significant findings are presented in bold. BSI: bronchiectasis severity index; PWV: pulse-wave velocity; NT-proBNP: N-terminal pro-brain natriuretic peptide; CRP: C-reactive protein; FEV₁: forced expiratory volume in 1 s; CT: computed tomography. ^#: significant after Hochberg adjustment for multiple comparisons; ^¶: significant at α<0.05.